Sage Revell is a market leader in the life sciences and technology sectors. She advises on national and cross-border mergers and acquisitions, venture capital, private equity, and corporate reorganizations. Sage represents emerging-growth companies and the investors who support them from the start-up phase, through growth stages, and all the way through to exit.
Sage was listed in The Top 25 Biotechnology and Life Sciences Attorneys of 2024 by Attorney Intel, which recognizes legal professionals who combine leading sector experience with advanced academic backgrounds in the life sciences fields, which enables them to provide unparalleled guidance across numerous legal issues.
Sage speaks and writes extensively on matters in the life sciences and technology sectors and is an advocate for women's health and wellness. She is frequently invited to present globally on these topics, including at the LSX World Congress, UCSF Rosenman Institute California, Startup Boston, Imperial College London, and The Guildhall.
Prior to joining Jones Day, Sage advised, amongst others: a global leader in its investments in developing, manufacturing, and marketing products for life sciences research and clinical trials; a fertility focused platform for clinical workflow and patient management; a health tech company that is enhancing medical imaging using artificial intelligence for early detection of cancers; a pharma company in developing a portfolio of transformative biological and well-being products for women; and a clinical stage biotech company in the men's health space.
Sage also has worked with conservation and water purification technology companies; a regulatory technology company involving digital currencies and blockchain-based financial ecosystem; a marine data intelligence company improving vessel efficiency through machine learning; and a French company specializing in packaging solutions for medical devices.
Esperienze
The following represents experience prior to joining Jones Day.
Advised Bio-Rad Laboratories Inc., a global leader in developing, manufacturing, and marketing products for life sciences research and clinical diagnostics, in its various investments (seed and several follow-on rounds) in the United Kingdom and beyond.
Advised WaWa Fertility, an IVF focused platform for billing, clinical workflow, and patient management.
Advised DeepLook Medical, a health tech company enhancing medical imaging using artificial intelligence (AI) for early detection of cancers.
Advised Viramal, a specialist pharma company based in the United Kingdom and Sweden, in developing a portfolio of transformative biological and vaginal well-being products for women.
Advised Antev, a clinical stage biotech company in the men's health space.
Advised Level, a global conservation business, principally active in the United Kingdom and Tanzania.
Advised Capricorn Sustainable Chemistry Fund on its investment into Econic Technologies, a cleantech company. This investment backed the scale up of Econic's catalyst and process technology that transforms waste CO2 into a valuable raw material for use in essential every day products, reducing their carbon footprints by up to 30%.
Advised an independent French company specializing in packaging solutions for medical devices on an asset sale to one of the world's largest independent pharmaceutical companies for more than €50 million.
Acted for the sellers on the sale of GreenSteam to Lloyd's Register. The acquisition will be integrated and managed by i4 Insight, a subsidiary of Lloyd's Register.
Altre Pubblicazioni
Prior Publications
August 2024
Catching the Herd of FemTech Unicorns, Financier Worldwide Magazine
February 2, 2024
Former Political Rivals Publish Report on Leading the Biotech Revolution, Mondaq
October 13, 2023
The Menopause Business – Collaboration on an article published by BTomorrow Ventures
January 29, 2021
Life sciences in the time of Covid-19 and its impact on the real estate sector, Global University Venturing
Prior Speaking Engagements
October 15, 2024
"AI & Data in Life Sciences: An Ethical Conundrum?" (Speaker) Bite Labs Pharma Event at the Guildhall in London
June 11, 2024
"Key Investment Trends - Catching The Herd of FemTech Unicorns" (Moderator) Decoding the Future of Women Conference in London
April 29, 2024
"Unveiling the Future - The Current Landscape and Spotlighting EU & UK Biotech and Pharma Excellence" (Moderator) LSX World Congress
February 24, 2024
"The Current State of Femtech & Upcoming Market Trends" (Keynote) Imperial College FemTech Conference in London
October 6, 2023
"Current Investment Trends in the US and UK" (Presenter) Law Firm Network EMEA Conference, Madrid
September 13, 2023
"The Female Frontier: A Conversation on FemTech" (Co-Speaker with Alice Zheng of Foreground Capital) Startup Boston Week
May 16, 2023
"The Current State of FemTech & Upcoming Market Trends" (Presenter) UCSF Rosenman Institute Webinar, California
"One of the best lawyers I've ever worked with."The Legal 500
- BPP Law School, London (Legal Practice Course 2012; Graduate Diploma in Law 2011); King's College London (B.Sc. in Mathematics 2010)
- Solicitor of the Senior Courts of England and Wales
"Next Generation Partner" and "Recommended Lawyer" in venture capital, M&A, and TMT, The Legal 500, where clients comment that she is "top-notch, highly intelligent, very hard working and very thorough … one of the best lawyers I've ever worked with" and has "relentless drive, focus and ambition"
"Ones to Watch" for life sciences law, The Best Lawyers in the United Kingdom
2025 Commercial Lawyer of the Year, Women and Diversity in Law
- French